The ST3P-UP Trial is a research study about how to support young adults with sickle cell disease as they prepare for moving to adult care.
An Open-Label, Expanded Access Protocol for Patients with Sickle Cell Disease Who Have No Alternative Treatment Options
Sickle Cell Disease
A Phase II, multicenter, randomized, open label two arm study comparing the effect of crizanlizumab + standard of care to standard of care alone on renal function in sickle cell disease patients ¡ý 16 years with chronic kidney disease due to sickle cell nephropathy (STEADFAST)
Sickle Cell Disease
Sitting in a conference room filled with more than 20 African American medical students, Johnson Haynes Jr., M.D., remembers not being able to see a face like his among his peers in that same building just 30 years ago.
